BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22506805)

  • 1. Comparison of citalopram and other selective serotonin reuptake inhibitor ingestions in children.
    Klein-Schwartz W; Benson BE; Lee SC; Litovitz T
    Clin Toxicol (Phila); 2012 Jun; 50(5):418-23. PubMed ID: 22506805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management.
    Nelson LS; Erdman AR; Booze LL; Cobaugh DJ; Chyka PA; Woolf AD; Scharman EJ; Wax PM; Manoguerra AS; Christianson G; Caravati EM; Troutman WG
    Clin Toxicol (Phila); 2007 May; 45(4):315-32. PubMed ID: 17486478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose.
    Isbister GK; Bowe SJ; Dawson A; Whyte IM
    J Toxicol Clin Toxicol; 2004; 42(3):277-85. PubMed ID: 15362595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SSRI safety in overdose.
    Barbey JT; Roose SP
    J Clin Psychiatry; 1998; 59 Suppl 15():42-8. PubMed ID: 9786310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric ingestion of vilazodone compared to other selective serotonin reuptake inhibitor medications.
    Russell JL; Spiller HA; Chounthirath T; Casavant MJ
    Clin Toxicol (Phila); 2017 Jun; 55(5):352-356. PubMed ID: 28421837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of toxicity of acute overdoses with citalopram and escitalopram.
    Hayes BD; Klein-Schwartz W; Clark RF; Muller AA; Miloradovich JE
    J Emerg Med; 2010 Jul; 39(1):44-8. PubMed ID: 19081700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escitalopram ingestions reported to Texas poison control centers, 2002-2005.
    Forrester MB
    Hum Exp Toxicol; 2007 Jun; 26(6):473-82. PubMed ID: 17698942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citalopram Overdose: a Fatal Case.
    Kraai EP; Seifert SA
    J Med Toxicol; 2015 Jun; 11(2):232-6. PubMed ID: 25326372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of dose and outcomes for pediatric vilazodone ingestions.
    Gaw CE; Spiller HA; Russell JL; Chounthirath T; Smith GA
    Clin Toxicol (Phila); 2018 Feb; 56(2):113-119. PubMed ID: 28705022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escitalopram causes fewer seizures in human overdose than citalopram.
    Yilmaz Z; Ceschi A; Rauber-Lüthy C; Sauer O; Stedtler U; Prasa D; Seidel C; Hackl E; Hoffmann-Walbeck P; Gerber-Zupan G; Bauer K; Kupferschmidt H; Kullak-Ublick GA; Wilks M
    Clin Toxicol (Phila); 2010 Mar; 48(3):207-12. PubMed ID: 20170390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective serotonin reuptake inhibitor exposure.
    Fitzgerald KT; Bronstein AC
    Top Companion Anim Med; 2013 Feb; 28(1):13-7. PubMed ID: 23796482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
    Assimon MM; Brookhart MA; Flythe JE
    J Am Soc Nephrol; 2019 Apr; 30(4):611-623. PubMed ID: 30885935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance with selective serotonin reuptake inhibitor triage guidelines by Texas poison control centers.
    Forrester MB; Parra G
    J Toxicol Environ Health A; 2008; 71(5):304-9. PubMed ID: 18214803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants.
    Oskotsky T; Maric I; Tang A; Oskotsky B; Wong RJ; Aghaeepour N; Sirota M; Stevenson DK
    JAMA Netw Open; 2021 Nov; 4(11):e2133090. PubMed ID: 34779847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes after supratherapeutic escitalopram ingestions.
    LoVecchio F; Watts D; Winchell J; Knight J; McDowell T
    J Emerg Med; 2006 Jan; 30(1):17-9. PubMed ID: 16434330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review and guide to selection of selective serotonin reuptake inhibitors.
    Edwards JG; Anderson I
    Drugs; 1999 Apr; 57(4):507-33. PubMed ID: 10235690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.
    Baumann P
    Clin Pharmacokinet; 1996 Dec; 31(6):444-69. PubMed ID: 8968657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citalopram overdose--review of cases treated in Swedish hospitals.
    Personne M; Sjöberg G; Persson H
    J Toxicol Clin Toxicol; 1997; 35(3):237-40. PubMed ID: 9140316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and ECG effects of escitalopram overdose.
    van Gorp F; Whyte IM; Isbister GK
    Ann Emerg Med; 2009 Sep; 54(3):404-8. PubMed ID: 19556032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.
    Preskorn SH
    Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.